PBT 0.00% 0.0¢ prana biotechnology limited

Breaking cycle of morbidity by PBT434, page-2

  1. 1,078 Posts.
    lightbulb Created with Sketch. 160
    There has been hopes that statins could break this cycle of morbidity in the elderly but only some 1/3 of the acute vascular problems can be avoided by statins. In fact statins do not seem to have much effect on how long we live. It takes care only of atherosclerosis but not strength of the arteries without atherosclerosis.
    Overload of iron promotes fission of mitochondria and this fission promotes vascular problems as strokes (Flippo KH et al, Sep 2018) when the walls of the arteries become weak even without atherosclerosis. So it is not only the cholesterol but also how well the endothelial cells can take care of it's strength and this needs that their energy supply works.
    Just about 25% of us will get a stroke during our life time. It is a possibility that PBT434 could help in this big problem and keep our arteries strong.
    Prana will have interesting times with Dr. Sinclair. Prana has been a neurodegeneration company but after this deal it will be " a age related degeneration company ".
 
watchlist Created with Sketch. Add PBT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.